Jeff Yass’s Design Therapeutics DSGN Stock Holding History

Jeff Yass’s Portfolio DSGN Stock Details DSGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,800	Closed	-$74.2K	–	12404
2024 Q3	$74.2K	Sell	13,800 -500	-3%	-$2.35K	﹤0.01%	11204
2024 Q2	$47.9K	Buy	+14,300	New	+$55.7K	﹤0.01%	11430
2024 Q1	–	Sell	-119,600	Closed	-$317K	–	12410
2023 Q4	$317K	Sell	119,600 -3,000	-2%	-$6.87K	﹤0.01%	9716
2023 Q3	$289K	Buy	+122,600	New	+$572K	﹤0.01%	9426
2023 Q1	–	Sell	-14,900	Closed	-$153K	–	12729
2022 Q4	$153K	Sell	14,900 -3,800	-20%	-$51.5K	﹤0.01%	10472
2022 Q3	$313K	Buy	+18,700	New	+$372K	﹤0.01%	9688

Other funds holding DSGN

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jeff Yass's DSGN Position: Q2 2026 in Review

Jeff Yass opened a new position in Design Therapeutics (DSGN) in Q2 2026: 15,650 shares worth $226K. The stake represents ﹤0.01% of the portfolio and ranks #11682 among its holdings. This is a return to the name: Jeff Yass previously reported a position in DSGN as recently as Q4 2025.

Jeff Yass first reported a position in DSGN in Q2 2022 and has held it in 15 quarters since. The position peaked at $1.75M in Q1 2023. 136 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

Jeff Yass held 15,650 shares of Design Therapeutics worth $226K as of Q2 2026.
Design Therapeutics was a new Jeff Yass position in Q2 2026.
Design Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11682 holding.
Jeff Yass first reported a position in Design Therapeutics in Q2 2022 and has held it in 15 quarters since.
Jeff Yass's Design Therapeutics position peaked at $1.75M in Q1 2023.
136 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.